Published in Arch Iran Med on March 01, 2011
Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol (2013) 2.58
Microscopic enteritis: Bucharest consensus. World J Gastroenterol (2015) 1.57
The likelihood ratio and frequency of DQ2/DQ8 haplotypes in Iranian patients with celiac disease. Gastroenterol Hepatol Bed Bench (2016) 0.80
Prevalence of serum celiac antibodies in a multiracial Asian population--a first study in the young Asian adult population of Malaysia. PLoS One (2015) 0.79
Pathological and Clinical Correlation between Celiac Disease and Helicobacter Pylori Infection; a Review of Controversial Reports. Middle East J Dig Dis (2016) 0.75
Effect of Helicobacter pylori on metabolic syndrome parameters in diabetic patients. Gastroenterol Hepatol Bed Bench (2016) 0.75
Relationship between Helicobacter pylori infection and celiac disease: a cross-sectional study and a brief review of the literature. Prz Gastroenterol (2017) 0.75
Helicobacter pylori-Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies. Diseases (2015) 0.75
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Helicobacter pylori infection. N Engl J Med (2002) 14.81
Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology (1992) 10.44
Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology (1992) 4.63
Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol (1999) 3.84
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut (2003) 3.30
Characterization of gastric mucosal lesions in patients with celiac disease: a prospective controlled study. Am J Gastroenterol (1999) 2.38
Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ (2004) 2.26
Lymphocytic gastritis in patients with celiac sprue or spruelike intestinal disease. Gastroenterology (1990) 2.08
High prevalence of coeliac disease in apparently healthy Iranian blood donors. Eur J Gastroenterol Hepatol (2003) 1.69
Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol (1995) 1.59
Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol (2005) 1.44
Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol (2009) 1.42
Microscopic enteritis: novel prospect in coeliac disease clinical and immuno-histogenesis. Evolution in diagnostic and treatment strategies. Dig Liver Dis (2008) 1.34
Grains of truth: evolutionary changes in small intestinal mucosa in response to environmental antigen challenge. Gut (1990) 1.21
Atypical presentation is dominant and typical for coeliac disease. J Gastrointestin Liver Dis (2009) 1.21
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica (2005) 1.17
Lymphocytic gastritis and coeliac disease: evidence of a positive association. J Clin Pathol (1998) 1.11
Duodenal intraepithelial lymphocytosis with normal villous architecture: common occurrence in H. pylori gastritis. Mod Pathol (2005) 1.08
Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran. J Gastroenterol Hepatol (2009) 1.05
Celiac disease and Hp infection association in Iran. Rev Esp Enferm Dig (2009) 1.05
Helicobacter pylori serology in patients with coeliac disease and dermatitis herpetiformis. J Clin Pathol (1992) 0.98
Helicobacter pylori infection in patients with celiac disease. Am J Gastroenterol (2006) 0.98
Analysis of 3'-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population. J Gastroenterol Hepatol (2009) 0.97
Lymphocytic gastritis: association with etiology and topology. Am J Surg Pathol (1999) 0.97
Small intestinal function and dietary status in dermatitis herpetiformis. Gut (1991) 0.92
Helicobacter pylori infection as a model for gastrointestinal immunity and chronic inflammatory diseases. Dig Dis (2001) 0.90
Helicobacter pylori infection and peptic disease in coeliac disease. Eur J Gastroenterol Hepatol (2000) 0.85
Celiac disease in 87 children with typical and atypical symptoms in Black Sea region of Turkey. World J Pediatr (2009) 0.83
Gastric histology and function tests in Italian patients with dermatitis herpetiformis. Scand J Gastroenterol (1990) 0.81
Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease. Scand J Gastroenterol (2001) 0.81
Malabsorption of vitamin B12 in dermatitis herpetiformis and its association with pernicious anaemia. Acta Med Scand (1986) 0.81
Helicobacter pylori and non-malignant diseases. Helicobacter (2005) 0.78
Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92
FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res (2007) 3.79
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology (2006) 3.68
Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med (2012) 3.35
The peopling of the Pacific from a bacterial perspective. Science (2009) 3.14
Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet (2005) 2.61
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl (2005) 2.43
A report card to grade Helicobacter pylori therapy. Helicobacter (2007) 2.41
Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int (2008) 2.39
Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology (2002) 2.32
Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res (2008) 2.08
Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology (2005) 2.03
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer (2004) 2.03
Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter (2011) 2.00
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91
Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol (2002) 1.91
Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol (2009) 1.89
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg (2007) 1.82
Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res (2006) 1.79
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol (2005) 1.79
Report of the 15th follow-up survey of primary liver cancer. Hepatol Res (2004) 1.78
High prevalence of coeliac disease in apparently healthy Iranian blood donors. Eur J Gastroenterol Hepatol (2003) 1.69
Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol (2005) 1.66
Nodular lymphoid hyperplasia in common variable immunodeficiency syndrome mimicking familial adenomatous polyposis on endoscopy. Indian J Pathol Microbiol (2009) 1.63
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res (2004) 1.60
Diagnosis of coeliac disease. Best Pract Res Clin Gastroenterol (2005) 1.60
Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery (2005) 1.54
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol (2005) 1.53
c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest (2012) 1.53
Frequent MSI mononucleotide markers for diagnosis of hereditary nonpolyposis colorectal cancer. Asian Pac J Cancer Prev (2010) 1.49
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs (2008) 1.48
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg (2002) 1.47
Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res (2002) 1.46
Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol (2005) 1.44
Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg (2005) 1.44
The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol (2011) 1.44
Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol (2011) 1.44
Perioperative changes in carbonylhemoglobin and methemoglobin during abdominal surgery: alteration in endogenous generation of carbon monoxide. J Gastroenterol Hepatol (2002) 1.43
Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol (2004) 1.42
Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology (2002) 1.39
24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study. J Gastrointestin Liver Dis (2009) 1.38
Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol (2011) 1.37
Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell (2005) 1.37
Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg (2002) 1.35
Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter (2004) 1.35
Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol (2002) 1.34
Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology (2003) 1.34
A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS One (2009) 1.34
Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter (2003) 1.31
Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg (2012) 1.28
Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res (2003) 1.28
Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol (2004) 1.27
Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis (2008) 1.25
Report of the 16th follow-up survey of primary liver cancer. Hepatol Res (2005) 1.25
Prevalence and pattern of antimicrobial resistance of Shigella species among patients with acute diarrhoea in Karaj, Tehran, Iran. J Health Popul Nutr (2003) 1.24
Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective. Expert Rev Gastroenterol Hepatol (2010) 1.24
Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol (2004) 1.23
Atypical presentation is dominant and typical for coeliac disease. J Gastrointestin Liver Dis (2009) 1.21
Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol (2003) 1.21
vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis (2008) 1.20
Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol (2008) 1.19
vacA i-region subtyping. Gastroenterology (2008) 1.18
Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem (2008) 1.17
Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg (2002) 1.17
Burden of hospitalization for gastrointestinal tract cancer patients - Results from a cross-sectional study in Tehran. Asian Pac J Cancer Prev (2009) 1.17
IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter (2008) 1.17
Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J Gastroenterol (2013) 1.16
The significance of virulence factors in Helicobacter pylori. J Dig Dis (2013) 1.16
Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol (2002) 1.16
Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol (2008) 1.15
Intra-familial prevalence of hepatitis B virologic markers in HBsAg positive family members in Nahavand, Iran. World J Gastroenterol (2005) 1.14
Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol (2009) 1.13
Comparison of genotyping Helicobacter pylori directly from biopsy specimens and genotyping from bacterial cultures. J Clin Microbiol (2003) 1.13
Primary hepatic carcinoid tumor with metachronous lymph node metastasis after long-term follow up. J Gastroenterol Hepatol (2002) 1.13
Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci (2004) 1.13
Frequency of HFE gene mutations in Iranian beta-thalassaemia minor patients. Eur J Haematol (2003) 1.12
Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun (2005) 1.12
Burden of hepatocellular carcinoma in Iran; Bayesian projection and trend analysis. Asian Pac J Cancer Prev (2010) 1.12
Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am (2003) 1.11
Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis. World J Gastroenterol (2008) 1.11
Discrimination of Entamoeba moshkovskii in patients with gastrointestinal disorders by single-round PCR. Jpn J Infect Dis (2010) 1.10
Pathogenesis of Helicobacter pylori Infection. Helicobacter (2005) 1.10
Management of adrenal metastasis from hepatocellular carcinoma. Surg Today (2002) 1.10
Study of Helicobacter pylori genotype status in saliva, dental plaques, stool and gastric biopsy samples. World J Gastroenterol (2012) 1.10
Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon (2011) 1.09
The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production. Infect Immun (2006) 1.09
Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci (2009) 1.09
Acute diarrhea due to enteropathogenic bacteria in patients at hospitals in Tehran. Jpn J Infect Dis (2008) 1.08
Four years incidence rate of colorectal cancer in Iran: a survey of national cancer registry data - implications for screening. Asian Pac J Cancer Prev (2012) 1.08
Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology (2003) 1.08
Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol (2006) 1.08